Solstice Neurosciences, Llc, A Subsidiary Of Us Worldmeds, Llc

This study tested a drug called MYOBLOC, injected into the salivary glands, to safely reduce drooling in 187 adults who had troublesome drooling for at least 3 months. The treatment decreased saliva production and improved symptoms compared to a placebo. It is designed to ease a …

This study tested whether injections of MYOBLOC (a botulinum toxin) into the saliva glands can safely reduce drooling in people with Parkinson's disease. Fifty-four participants received either the drug or a placebo, and researchers measured changes in drooling frequency and seve…

This study tested the safety and effectiveness of repeated MYOBLOC injections over one year in 187 adults with troublesome drooling caused by conditions like Parkinson's disease, stroke, or ALS. Participants received up to four treatment sessions, and researchers monitored side e…